OTCBB:RGBPP

Regen Biopharma Stock News

Healthcare > Biotechnology

Buy RGBPP

*Your capital is at risk

$0.0045

+0 (+0%)

At Close: Jul 31, 2026

Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine

07:40pm, Wednesday, 17'th Nov 2021 PR Newswire

SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP) is currently completing a strategic analysis of its next 5 years of growth. As part of this analysis, diversifying beyond therapeutics into in-vitro diagnostics has been deemed a strategic

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by